| MORPHOSYS AG O.N. | 46.5600 / -7.44% |
| Date/Time | 07/27 / 09:15 |
| Chg. / Chg.(%) | -3.7400 / -7.44% |
| Bid | - |
| Ask | - |
| Open | 49.8000 |
| Previous Close | 50.3000 |
| High | 49.8000 |
| Low | 46.5600 |
| Volume [EUR] | 88,765.9500 |
| Volume [Units] | 1,816 |
| Price fixings | 14 |
| ISIN | DE0006632003 |
| Security | MOR |
| Exchange | Frankfurt |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 46.100 |  |
156,938 |
| TradeGate | 46.300 | |
58,639 |
| Cboe Europe .. | 46.60 | |
13,310 |
| Stuttgart | 46.600 | |
5,252 |
| Quotrix | 46.0300 | |
4,475 |
| gettex | 46.340 | |
4,088 |
| Turquoise | 46.44 | |
2,134 |
| London Inter.. | 46.27 | |
1,873 |
| Frankfurt | 46.5600 | |
1,816 |
| Hamburg | 49.20 | |
100 |
| Düsseldorf | 49.28 | |
60 |
| Vienna Globa.. | 47.83 | |
0 |
| Hannover | 49.20 | |
0 |
| Berlin | 49.41 | |
0 |
| München | 49.50 | |
0 |
| Lang & Schwa.. | 45.620 | |
|
| Cboe Europe .. | 50.06 | 56 | |
| Cboe Europe .. | 53.52 | 48 | |
| Nasdaq Other.. | 84.7500 | 100 | |
| EUREX | Options | ||
News
- CONSTELLATION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CNST and Encourages Investors to Contact the Firm
06/03/2021 / 20:27 - GlobeNewswire - Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership With MorphoSys
06/02/2021 / 13:40 - GlobeNewswire - I-Mab and MorphoSys Announce First Patient Dosed in Phase 3 Clinical Trial of TJ202/MOR202 in r/r Multiple Myeloma in Mainland China
04/27/2020 / 22:01 - GlobeNewswire - MOR106 clinical development in atopic dermatitis stopped for futility
10/28/2019 / 21:45 - GlobeNewswire - Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
04/23/2019 / 22:02 - GlobeNewswire
Real-time